Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Danaher Corporation

DHR
Current price
6.14 EUR 0 EUR (0.00%)
Last closed 241.53 USD
ISIN US2358511028
Sector Healthcare
Industry Diagnostics & Research
Exchange Frankfurt Exchange
Capitalization 174 451 081 216 USD
Yield for 12 month +15.00 %
1Y
3Y
5Y
10Y
15Y
DHR
21.11.2021 - 28.11.2021

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia. Address: 2200 Pennsylvania Avenue, North West, Washington, DC, United States, 20037-1701

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

289.42 USD

P/E ratio

45.2303

Dividend Yield

0.45 %

Current Year

+23 890 000 000 USD

Last Year

+31 471 000 000 USD

Current Quarter

+5 798 000 000 USD

Last Quarter

+5 743 000 000 USD

Current Year

+14 034 000 000 USD

Last Year

+18 949 000 000 USD

Current Quarter

+3 401 000 000 USD

Last Quarter

+3 428 000 000 USD

Key Figures DHR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 7 511 000 064 USD
Operating Margin TTM 20.34 %
PE Ratio 45.2303
Return On Assets TTM 3.86 %
PEG Ratio 2.8382
Return On Equity TTM 7.59 %
Wall Street Target Price 289.42 USD
Revenue TTM 23 741 999 104 USD
Book Value 71.03 USD
Revenue Per Share TTM
Dividend Share 1.05 USD
Quarterly Revenue Growth YOY 3.1 %
Dividend Yield 0.45 %
Gross Profit TTM 18 949 000 000 USD
Earnings per share 5.34 USD
Diluted Eps TTM 5.34 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY -26 %
Profit Margin 16.39 %

Dividend Analytics DHR

Dividend growth over 5 years

74 %

Continuous growth

6 years

Payout Ratio 5 years average

11 %

Dividend History DHR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.08
Ex Dividend Date 27.09.2024
Forward Annual Dividend Yield 0.45 %
Last Split Factor 1128:1000
Payout Ratio 14.11 %
Last Split Date 02.10.2023
Dividend Date 25.10.2024

Stock Valuation DHR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 45.2303
Forward PE 28.4091
Enterprise Value Revenue 7.9752
Price Sales TTM 7.3478
Enterprise Value EBITDA 26.3716
Price Book MRQ 3.4007

Financials DHR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DHR

For 52 weeks

205.44 USD 281.43 USD
50 Day MA 263.4 USD
Shares Short Prior Month 5 644 106
200 Day MA 256.9 USD
Short Ratio 2.18
Shares Short 5 213 324
Short Percent 0.81 %